Cargando…
Are intravenous corticosteroid pulses superior to low dose corticosteroids in patients with severe Covid-19?
Corticosteroids were the first drugs proven to reduce mortality in Covid-19. In June 2020, the RECOVERY group announced the results of their seminal trial showing dexamethasone 6 mg per day was able to reduce 28-day mortality in hospitalized patients with Covid needing supplemental oxygen or mechani...
Autores principales: | Cordeiro Veiga, Viviane, Biasi Cavalcanti, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248174/ https://www.ncbi.nlm.nih.gov/pubmed/35777764 http://dx.doi.org/10.1183/13993003.01220-2022 |
Ejemplares similares
-
Age, host response, and mortality in COVID-19
por: Veiga, Viviane Cordeiro, et al.
Publicado: (2023) -
Comparison of High-Dose Corticosteroid Pulse Therapy and Combination Therapy Using Oral Cyclosporine with Low-Dose Corticosteroid in Severe Alopecia Areata
por: Yeo, In Kwon, et al.
Publicado: (2015) -
COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial
Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020) -
Corticosteroids in severe COVID-19: a critical view of the evidence
por: De Backer, Daniel, et al.
Publicado: (2020) -
Back to the Basics: Response of Alopecia Areata Universalis to Intravenous High-Dose Pulse Corticosteroid Therapy
por: Plachouri, Kerasia-Maria, et al.
Publicado: (2021)